Journal
JOURNAL OF HEMATOLOGY & ONCOLOGY
Volume 10, Issue -, Pages -Publisher
BIOMED CENTRAL LTD
DOI: 10.1186/s13045-017-0410-6
Keywords
RNA modification; m(6)A; Leukemia; Acute myeloid leukemia; TP53 mutation
Categories
Funding
- National Health and Medical Research Council of Australia [1061906, 1080530, 1128175, 1126306]
- Cancer Council of NSW
- Cure the Future
- an anonymous foundation
- Cancer Institute of NSW
- National Health and Medical Research Council of Australia [1126306] Funding Source: NHMRC
Ask authors/readers for more resources
Methylation of N-6 adenosine (m(6)A) is known to be important for diverse biological processes including gene expression control, translation of protein, and messenger RNA (mRNA) splicing. However, its role in the development of human cancers is poorly understood. By analyzing datasets from the Cancer Genome Atlas Research Network (TCGA) acute myeloid leukemia (AML) study, we discover that mutations and/or copy number variations of m(6)A regulatory genes are strongly associated with the presence of TP53 mutations in AML patients. Further, our analyses reveal that alterations in m(6)A regulatory genes confer a worse survival in AML. Our work indicates that genetic alterations of m(6)A regulatory genes may cooperate with TP53 and/or its regulator/downstream targets in the pathogenesis and/or maintenance of AML.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available